Hantech Bio-Technology Co

Hantech Bio-Technology Co Financial Leverage

The Financial Leverage (Equity Multiplier) of Hantech Bio-Technology Co (1294.TWO) as of Oct 28, 2026 is 1.41. In the previous year, Financial Leverage (Equity Multiplier) was 1.37 — a change of 2.80% (higher).

Financial Leverage

1.41

YoY

2.80%

Last updated:

Financial Leverage (Equity Multiplier) of Hantech Bio-Technology Co is 2025 1.41 . Financial Leverage (Equity Multiplier) of Hantech Bio-Technology Co was 2024 1.37 . It decreases by 2.80% higher compared to the previous year.

The Hantech Bio-Technology Co Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2019
1.51 TWD
Jan 1, 2020
2.17 TWD
Jan 1, 2021
2.15 TWD
Jan 1, 2022
1.77 TWD
Jan 1, 2023
2.34 TWD
Jan 1, 2024
1.37 TWD
Jan 1, 2025
1.41 TWD
The Hantech Bio-Technology Co Financial Leverage history
YEARFinancial LeverageYoY
1.41+2.80%
1.37-41.49%
2.34+31.79%
1.77-17.51%
2.15-1.04%
2.17+43.93%
1.51—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Hantech Bio-Technology Co Stock analysis

What does Hantech Bio-Technology Co do? Hantech Bio-Technology Co., Ltd. generates revenue by manufacturing and selling science-based health products, eco-friendly pouches, and dietary supplements. The company provides functional drinks, including health drinks and crystal jelly, and powder raw materials and capsules such as pearl powder and tortoise-deer concentrated powder. Products are sold to markets in China, Southeast Asia, and America, with packaging options ranging from square bags to wine bottle bags in capacities of 10-80ml (g). The firm focuses on functional drink production, offering health drinks and crystal jelly in various shaped pouches like round mouth bottles, Z-shaped bags, and stand-up bags. Powder raw materials and capsule products include pearl powder and tortoise-deer concentrated powder, targeting consumers seeking health and wellness solutions. Sales are distributed across China, Southeast Asia, and American regions. Hantech Bio-Technology Co., Ltd. serves customers in China, Southeast Asia, and America through its eco-friendly packaging solutions and science-based health products. The company’s product portfolio includes functional drinks, crystal jelly, and dietary supplements with diverse packaging formats. Sales are driven by the demand for health-focused products in these key markets. Hantech Bio-Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hantech Bio-Technology Co stock

Financial Leverage (Equity Multiplier) of Hantech Bio-Technology Co is 1.41 in 2025.

Financial Leverage (Equity Multiplier) of Hantech Bio-Technology Co changed from 1.37 to 1.41, representing a 2.80% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Hantech Bio-Technology Co since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Hantech Bio-Technology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — Hantech Bio-Technology Co

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Hantech Bio-Technology Co